Kalbe Farma Tbk PT
XMUN:LCLA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Kalbe Farma Tbk PT
XMUN:LCLA
|
ID |
|
D
|
Darling Ingredients Inc
F:43D
|
US |
|
H
|
Halliburton Co
DUS:HAL
|
US |
|
B
|
BlackRock Inc
XMUN:BLQA
|
US |
|
Warner Bros Discovery Inc
F:J5A
|
US |
|
B
|
Bper Banca SpA
XBER:4BE
|
IT |
|
C
|
Cadeler A/S
NYSE:CDLR
|
DK |
|
Meier Tobler Group AG
SIX:MTG
|
CH |
|
Sulzer AG
SIX:SUN
|
CH |
|
L
|
Legrand SA
SWB:LRC
|
FR |
|
H
|
Henderson Land Development Co Ltd
SWB:HLD
|
HK |
|
E
|
European Lithium Ltd
F:PF8
|
AU |
|
B
|
Benefit Systems SA
WSE:BFT
|
PL |
|
S
|
SoftBank Group Corp
OTC:SFTBF
|
JP |
|
Lumibird SA
F:QTL
|
FR |
|
S
|
Swiss Re AG
SWB:SR9A
|
CH |
|
S
|
Societe Generale SA
XBER:SGE
|
FR |
|
S
|
Stockland Corporation Ltd
F:LN1
|
AU |
|
Fujikura Ltd
OTC:FKURF
|
JP |
|
A
|
Alphamin Resources Corp
OTC:AFMJF
|
MU |
Bankruptcy Probability
Kalbe Farma Tbk PT's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Kalbe Farma Tbk PT Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ID |
|
Kalbe Farma Tbk PT
IDX:KLBF
|
35.5T IDR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
618.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
317B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
237.9B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
184.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
250.7B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Kalbe Farma Tbk PT's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Kalbe Farma Tbk PT has total debt of 282.3B IDR. This includes both short-term (110.4B IDR) and long-term (171.9B IDR) debt.
You can find a full breakdown on its Balance Sheet.
